Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study-Reference-Cited by-同舟云学术

Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

Published:2005-10-06 Issue:3 Volume:21 Page:343-353
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Oertel Wolfgang H.,Wolters Erik,Sampaio Cristina,Gimenez-Roldan Santiago,Bergamasco Bruno,Dujardin Max,Grosset Donald G.,Arnold Guy,Leenders Klaus L.,Hundemer Hans-Peter,Lledó Alberto,Wood Andrew,Frewer Paul,Schwarz Johannes

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference34 articles.

1. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines;Olanow;Mov Disord,2001

2. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up;Montastruc;J Neurol Neurosurg Psychiatry,1994

3. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa;Hely;J Neurol Neurosurg Psychiatry,1994

4. Evolution of motor fluctuations in Parkinson's disease: a longitudinal study over 6 years;Reardon;Mov Disord,1999

5. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa;Rascol;N Engl J Med,2000

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose–response relationship of levodopa with dyskinesia in Parkinson's disease: A systematic review and meta-analysis;Heliyon;2024-03

2. Continuous dopaminergic stimulation and the transition to using continuous drug delivery in Parkinson's disease—An introduction;International Review of Movement Disorders;2024

3. Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis;European Journal of Pharmacology;2023-09

4. Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions;Journal of Clinical Medicine;2023-06-30

5. Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa‐Induced Dyskinesia;Movement Disorders;2023-01-19